LIGAND PHARMACEUTICALS INC - COM NEW (LGND)

Q3 2019 13F Portfolio Holders as of 9/30/2019

Type / Class
Equity / COM NEW
Number of holders
270
Total Shares
23.3M
Shares change
-1.53M
Total reported value, excl. options
$2.32B
Value change
-$162M
Put/Call ratio
6.39
Number of buys
88
Number of sells
-175
Price
$99.54
Investor Option Weight % Change % Value $ * Price $ Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.